Showing results (1581-1590 of 3,638) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|October 24, 2012
Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acidJason Young, Nancy A Nickman, Joseph E Biskupiak, et al.Breast (Edinburgh, Scotland)|October 25, 2012
Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: a review of the literatureKimberly A Boswell, Xufang Wang, Manasee V Shah, et al.Breast (Edinburgh, Scotland)|January 28, 2015
Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer studyL Fallowfield, S Osborne, C Langridge, et al.Breast (Edinburgh, Scotland)|July 17, 2012
Trends in tertiary breast reconstruction: literature review and single centre experienceAnita T Mohan, Yazan Al-Ajam, Afshin MosahebiBreast (Edinburgh, Scotland)|April 18, 2015
Breast cancer brain metastases - A 12 year review of treatment outcomesP B De Ieso, U Schick, N Rosenfelder, et al.Breast (Edinburgh, Scotland)|February 24, 2015
2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practiceIlaria Pennacchia, Arnaldo Carbone, Arcangelo Di Cerbo, et al.Breast (Edinburgh, Scotland)|April 26, 2021
A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropeniaMark Clemons, Dean Fergusson, Anil A Joy, et al.Breast (Edinburgh, Scotland)|October 23, 2012
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patientsLea Regolo, Licia Galli, Gianfranco Petrolo, et al.Breast (Edinburgh, Scotland)|October 23, 2012
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumoursEmad A Rakha, Puay Hoon Tan, Abeer Shaaban, et al.Breast (Edinburgh, Scotland)|May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.Pageof 364